Published June 2021 | Version v1
Journal article Metadata-only

Use of radiotherapy in breast cancer patients with brain metastases: a retrospective 11-year single center study

Creators

  • 1. Department of Life Sciences and Health, Oslo Metropolitan University, Faculty of Health Sciences, Oslo (Norway)
  • 2. Institute of Clinical Medicine, University of (Norway)
  • 3. European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, Oslo (Norway)
  • 4. Department of Medical Physics, Oslo University Hospital, Oslo (Norway)
  • 5. Department of Cancer Treatment, Oslo University Hospital, Oslo (Norway)

Description

Highlights: • The use of SRS in breast cancer treatment is increasing. • The use of WBRT in patients with ≥5 brain metastases is decreasing. • Patients with good performance status (ECOG 0) or treated with additional surgery had superior overall survival. To analyse the use of radiotherapy (RT) and factors affecting overall survival (OS) after RT in breast cancer patients with brain metastases.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.jmir.2021.01.002

Additional details

Identifiers

DOI
10.1016/j.jmir.2021.01.002;
PII
S1939865421000023;

Publishing Information

Journal Title
Journal of Medical Imaging and Radiation Sciences
Journal Volume
52
Journal Issue
2
Journal Page Range
p. 214-222
ISSN
1939-8654

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54017652
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BRAIN; FRACTIONATION; MAMMARY GLANDS; METASTASES; NEOPLASMS; PATIENTS; RADIOTHERAPY; SURGERY
Descriptors DEC
BODY; CENTRAL NERVOUS SYSTEM; DISEASES; GLANDS; MEDICINE; NERVOUS SYSTEM; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; SEPARATION PROCESSES; THERAPY

Optional Information

Copyright
Copyright (c) 2021 Published by Elsevier Inc. on behalf of Canadian Association of Medical Radiation Technologists.